Prexasertib mesylate (Synonyms: Prexasertib mesylate; LY2606368; LY-2606368; LY 2606368.) |
| Catalog No.GB62181 |
Prexasertib, also known as LY2606368, is a potent and selective Chk1/Chk2 inhibitor.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1234015-55-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Prexasertib, also known as LY2606368, is a potent and selective Chk1/Chk2 inhibitor. Prexasertib increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia. LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms. Treatment of cells with LY2606368 results in the rapid appearance of TUNEL and pH2AX-positive double-stranded DNA breaks in the S-phase cell population.
Review for Prexasertib mesylate
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Prexasertib mesylate
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *